
IQVIA Holdings Inc. (IQV), a large-cap growth stock in the Biotechnology & Drugs sector, received a 77% rating from Validea's P/B Growth Investor model, based on Partha Mohanram's academically-backed strategy. This model, designed to identify sustainable growth in low book-to-market stocks and historically outperforming, noted IQV's strong fundamentals in areas such as asset returns and cash flow. While the 77% score is just below the 80% 'some interest' threshold for the strategy, it highlights IQV as a notable growth candidate based on rigorous fundamental analysis.
IQVIA Holdings Inc. (IQV) exhibits strong underlying fundamentals according to Validea's P/B Growth Investor model, which is based on Partha Mohanram's academic strategy for identifying sustainable growth stocks. The company scored a 77%, a moderately positive rating that sits just below the 80% threshold typically indicating model interest. The analysis highlights IQV's strengths in key areas, passing tests for its book-to-market ratio, return on assets (ROA), and cash flow from operations relative to assets. Furthermore, the company shows stability by passing criteria for low variance in both ROA and sales, suggesting consistent operational performance. However, the model also flagged weaknesses, as IQV failed the tests for Advertising to Assets and Research and Development to Assets. This suggests that while the company is efficient and profitable, its investment in key growth drivers like R&D and marketing, relative to its asset size, is lower than what the model deems optimal for a premier growth candidate.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment